TY - JOUR AU - Thomas, A. AU - Teicher, B. A. AU - Hassan, R. PY - 2016 DA - 2016// TI - Antibody–drug conjugates for cancer therapy JO - Lancet Oncol VL - 17 UR - https://doi.org/10.1016/S1470-2045(16)30030-4 DO - 10.1016/S1470-2045(16)30030-4 ID - Thomas2016 ER - TY - JOUR AU - Firer, M. A. AU - Gellerman, G. PY - 2012 DA - 2012// TI - Targeted drug delivery for cancer therapy: the other side of antibodies JO - J Hematol Oncol VL - 5 UR - https://doi.org/10.1186/1756-8722-5-70 DO - 10.1186/1756-8722-5-70 ID - Firer2012 ER - TY - JOUR AU - Firer, M. A. AU - Laptev, R. AU - Kasatkin, I. AU - Trombka, D. PY - 2003 DA - 2003// TI - Specific destruction of hybridoma cells by antigen-toxin conjugates demonstrate an efficient strategy for targeted drug therapy in leukemias of the B cell lineage JO - Leuk Lymphoma VL - 44 UR - https://doi.org/10.1080/1042819031000063381 DO - 10.1080/1042819031000063381 ID - Firer2003 ER - TY - JOUR AU - Gellerman, G. AU - Baskin, S. AU - Galia, L. AU - Gilad, Y. AU - Firer, M. A. PY - 2013 DA - 2013// TI - Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide JO - Anticancer Drugs VL - 24 UR - https://doi.org/10.1097/CAD.0b013e32835bb17a DO - 10.1097/CAD.0b013e32835bb17a ID - Gellerman2013 ER - TY - JOUR AU - Cohen, S. PY - 2007 DA - 2007// TI - Specific targeting to murine myeloma cells of Cyt1Aa toxin from Bacillus thuringiensis subspecies israelensis JO - J Biol Chem VL - 282 UR - https://doi.org/10.1074/jbc.M703567200 DO - 10.1074/jbc.M703567200 ID - Cohen2007 ER - TY - JOUR AU - Gilad, Y. PY - 2014 DA - 2014// TI - ‘Switch off/switch on’ regulation of drug cytotoxicity by conjugation to a cell targeting peptide JO - Eur J Med Chem VL - 85 UR - https://doi.org/10.1016/j.ejmech.2014.07.073 DO - 10.1016/j.ejmech.2014.07.073 ID - Gilad2014 ER - TY - JOUR AU - Gilad, Y. PY - 2015 DA - 2015// TI - Dual-drug RGD conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells JO - Biopolymers ID - Gilad2015 ER - TY - JOUR AU - Gilad, Y. PY - 2016 DA - 2016// TI - Synthesis, biological studies and molecular dynamics of new anticancer RGD-based peptide conjugates for targeted drug delivery JO - Bioorg Med Chem VL - 24 UR - https://doi.org/10.1016/j.bmc.2015.12.020 DO - 10.1016/j.bmc.2015.12.020 ID - Gilad2016 ER - TY - JOUR AU - Du, A. W. AU - Stenzel, M. H. PY - 2014 DA - 2014// TI - Drug carriers for the delivery of therapeutic peptides JO - Biomacromol VL - 15 UR - https://doi.org/10.1021/bm500169p DO - 10.1021/bm500169p ID - Du2014 ER - TY - JOUR AU - Pérez-Ortiz, M. PY - 2017 DA - 2017// TI - Gold nanoparticles as an efficient drug delivery system for GLP-1 peptides JO - Colloids Surf B Biointerfaces VL - 158 UR - https://doi.org/10.1016/j.colsurfb.2017.06.015 DO - 10.1016/j.colsurfb.2017.06.015 ID - Pérez-Ortiz2017 ER - TY - JOUR AU - Wang, Y. F. AU - Liu, L. AU - Xue, X. AU - Liang, X. J. PY - 2017 DA - 2017// TI - Nanoparticle-based drug delivery systems: what can they really do in vivo? JO - F1000Research VL - 6 UR - https://doi.org/10.12688/f1000research.9690.1 DO - 10.12688/f1000research.9690.1 ID - Wang2017 ER - TY - JOUR AU - Jurj, A. PY - 2017 DA - 2017// TI - The new era of nanotechnology, an alternative to change cancer treatment JO - Drug Des Dev Ther VL - 11 UR - https://doi.org/10.2147/DDDT.S142337 DO - 10.2147/DDDT.S142337 ID - Jurj2017 ER - TY - JOUR AU - Mendes, R. AU - Fernandes, A. AU - Baptista, P. PY - 2017 DA - 2017// TI - Gold nanoparticle approach to the selective delivery of gene silencing in cancer—the case for combined delivery JO - Genes (Basel) VL - 8 UR - https://doi.org/10.3390/genes8030094 DO - 10.3390/genes8030094 ID - Mendes2017 ER - TY - JOUR AU - Ghosh, P. AU - Han, G. AU - De, M. AU - Kim, C. AU - Rotello, V. PY - 2008 DA - 2008// TI - Gold nanoparticles in delivery applications JO - Adv Drug Deliv Rev VL - 60 UR - https://doi.org/10.1016/j.addr.2008.03.016 DO - 10.1016/j.addr.2008.03.016 ID - Ghosh2008 ER - TY - JOUR AU - Rana, S. AU - Bajaj, A. AU - Mout, R. AU - Rotello, V. M. PY - 2012 DA - 2012// TI - Monolayer coated gold nanoparticles for delivery applications JO - Adv Drug Deliv Rev VL - 64 UR - https://doi.org/10.1016/j.addr.2011.08.006 DO - 10.1016/j.addr.2011.08.006 ID - Rana2012 ER - TY - JOUR AU - Jong, W. H. AU - Borm, P. J. A. PY - 2008 DA - 2008// TI - Drug delivery and nanoparticles: applications and hazards JO - Int J Nanomed VL - 3 UR - https://doi.org/10.2147/IJN.S596 DO - 10.2147/IJN.S596 ID - Jong2008 ER - TY - JOUR AU - Comenge, J. PY - 2012 DA - 2012// TI - Detoxifying antitumoral drugs via nanoconjugation: the case of gold nanoparticles and cisplatin JO - PLoS ONE VL - 7 UR - https://doi.org/10.1371/journal.pone.0047562 DO - 10.1371/journal.pone.0047562 ID - Comenge2012 ER - TY - JOUR AU - Wilhelm, S. PY - 2016 DA - 2016// TI - Analysis of nanoparticle delivery to tumours JO - Nat Rev Mater VL - 1 UR - https://doi.org/10.1038/natrevmats.2016.14 DO - 10.1038/natrevmats.2016.14 ID - Wilhelm2016 ER - TY - JOUR AU - Huang, K. PY - 2012 DA - 2012// TI - Size-dependent localization and penetration of ultrasmall gold nanoparticles in cancer cells, multicellular spheroids, and tumors in vivo JO - ACS Nano VL - 6 UR - https://doi.org/10.1021/nn301282m DO - 10.1021/nn301282m ID - Huang2012 ER - TY - JOUR AU - Xu, S. PY - 2014 DA - 2014// TI - Novel hybrids of natural oridonin-bearing nitrogen mustards as potential anticancer drug candidates JO - ACS Med Chem Lett VL - 5 UR - https://doi.org/10.1021/ml500141f DO - 10.1021/ml500141f ID - Xu2014 ER - TY - JOUR AU - Bashari, O. PY - 2017 DA - 2017// TI - Discovery of peptide drug carrier candidates for targeted multi-drug delivery into prostate cancer cells JO - Cancer Lett VL - 408 UR - https://doi.org/10.1016/j.canlet.2017.08.040 DO - 10.1016/j.canlet.2017.08.040 ID - Bashari2017 ER - TY - JOUR AU - Hühn, J. PY - 2017 DA - 2017// TI - Selected standard protocols for the synthesis, phase transfer, and characterization of inorganic colloidal nanoparticles JO - Chem Mater VL - 29 UR - https://doi.org/10.1021/acs.chemmater.6b04738 DO - 10.1021/acs.chemmater.6b04738 ID - Hühn2017 ER - TY - JOUR AU - Beija, M. PY - 2010 DA - 2010// TI - Control of the catalytic properties and directed assembly on surfaces of MADIX/RAFT polymer-coated gold nanoparticles by tuning polymeric shell charge JO - J Mater Chem VL - 20 UR - https://doi.org/10.1039/c0jm01781g DO - 10.1039/c0jm01781g ID - Beija2010 ER - TY - JOUR AU - Zhang, Z. AU - Liu, Y. AU - Jarreau, C. AU - Welch, M. J. AU - Taylor, J. S. A. PY - 2013 DA - 2013// TI - Nucleic acid-directed self-assembly of multifunctional gold nanoparticle imaging agents JO - Biomater Sci VL - 1 UR - https://doi.org/10.1039/c3bm60070j DO - 10.1039/c3bm60070j ID - Zhang2013 ER - TY - JOUR AU - Manson, J. AU - Kumar, D. AU - Meenan, B. J. AU - Dixon, D. PY - 2011 DA - 2011// TI - Polyethylene glycol functionalized gold nanoparticles: the influence of capping density on stability in various media JO - Gold Bull VL - 44 UR - https://doi.org/10.1007/s13404-011-0015-8 DO - 10.1007/s13404-011-0015-8 ID - Manson2011 ER - TY - JOUR AU - Assadi, A. PY - 2016 DA - 2016// TI - Novel chlorambucil-conjugated anionic linear-globular PEG-based second-generation dendrimer: in vitro/in vivo improved anticancer activity JO - OncoTargets Ther VL - 9 UR - https://doi.org/10.2147/OTT.S103487 DO - 10.2147/OTT.S103487 ID - Assadi2016 ER - TY - JOUR AU - Khan, I. PY - 2016 DA - 2016// TI - Biodegradable nano-architectural PEGylated approach for the improved stability and anticancer efficacy of bendamustine JO - Int J Biol Macromol VL - 92 UR - https://doi.org/10.1016/j.ijbiomac.2016.08.004 DO - 10.1016/j.ijbiomac.2016.08.004 ID - Khan2016 ER - TY - JOUR AU - Ajazuddin AU - Alexander, A. AU - Amarji, B. AU - Kanaujia, P. PY - 2013 DA - 2013// TI - Synthesis, characterization and in vitro studies of pegylated melphalan conjugates JO - Drug Dev Ind Pharm VL - 39 UR - https://doi.org/10.3109/03639045.2012.702346 DO - 10.3109/03639045.2012.702346 ID - Ajazuddin2013 ER - TY - JOUR AU - Omidfar, K. AU - Daneshpour, M. PY - 2015 DA - 2015// TI - Advances in phage display technology for drug discovery JO - Expert Opin Drug Discov VL - 10 UR - https://doi.org/10.1517/17460441.2015.1037738 DO - 10.1517/17460441.2015.1037738 ID - Omidfar2015 ER - TY - JOUR AU - Wang, Y. PY - 2017 DA - 2017// TI - Peptide–drug conjugates as effective prodrug strategies for targeted delivery JO - Adv Drug Deliv Rev VL - 110–111 UR - https://doi.org/10.1016/j.addr.2016.06.015 DO - 10.1016/j.addr.2016.06.015 ID - Wang2017 ER - TY - JOUR AU - Arimany-Nardi, C. PY - 2015 DA - 2015// TI - Human organic cation transporter 1 (hOCT1) as a mediator of bendamustine uptake and cytotoxicity in chronic lymphocytic leukemia (CLL) cells JO - Pharmacogenomics J VL - 15 UR - https://doi.org/10.1038/tpj.2014.77 DO - 10.1038/tpj.2014.77 ID - Arimany-Nardi2015 ER - TY - JOUR AU - Gupta, S. PY - 2012 DA - 2012// TI - Human organic cation transporter 1 is expressed in lymphoma cells and increases susceptibility to irinotecan and paclitaxel JO - J Pharmacol Exp Ther VL - 341 UR - https://doi.org/10.1124/jpet.111.190561 DO - 10.1124/jpet.111.190561 ID - Gupta2012 ER - TY - JOUR AU - Hill, B. T. PY - 1972 DA - 1972// TI - Studies on the transport and cellular distribution of chlorambucil in the yoshida ascites sarcoma JO - Biochem Pharmacol VL - 21 UR - https://doi.org/10.1016/0006-2952(72)90322-X DO - 10.1016/0006-2952(72)90322-X ID - Hill1972 ER - TY - JOUR AU - Asher Begletter, G. AU - Goldenberg, J. PY - 1983 DA - 1983// TI - Uptake and decomposition of chlorambucil by L5178y lymphoblasts in vitro JO - Biochem Pharmacol VL - 32 UR - https://doi.org/10.1016/0006-2952(83)90535-X DO - 10.1016/0006-2952(83)90535-X ID - Asher Begletter1983 ER - TY - JOUR AU - Uchino, H. PY - 2002 DA - 2002// TI - Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition JO - Mol Pharmacol VL - 61 UR - https://doi.org/10.1124/mol.61.4.729 DO - 10.1124/mol.61.4.729 ID - Uchino2002 ER - TY - JOUR AU - Hayashi, K. AU - Anzai, N. PY - 2017 DA - 2017// TI - Novel therapeutic approaches targeting L-type amino acid transporters for cancer treatment JO - World J Gastrointest Oncol VL - 9 UR - https://doi.org/10.4251/wjgo.v9.i1.21 DO - 10.4251/wjgo.v9.i1.21 ID - Hayashi2017 ER - TY - JOUR AU - Keating, M. J. AU - Bach, C. AU - Yesothan, U. AU - Kirkpatrick, P. PY - 2008 DA - 2008// TI - Bendamustine JO - Nat Rev Drug Discov VL - 7 UR - https://doi.org/10.1038/nrd2596 DO - 10.1038/nrd2596 ID - Keating2008 ER - TY - JOUR AU - Knauf, W. U. PY - 2012 DA - 2012// TI - Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial JO - Br J Haematol VL - 159 UR - https://doi.org/10.1111/bjh.12000 DO - 10.1111/bjh.12000 ID - Knauf2012 ER - TY - JOUR AU - Leoni, L. M. PY - 2008 DA - 2008// TI - Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-07-1061 DO - 10.1158/1078-0432.CCR-07-1061 ID - Leoni2008 ER - TY - JOUR AU - Ehrsson, H. AU - Eksborg, S. AU - Wallin, I. AU - Nilsson, S. -. O. PY - 1980 DA - 1980// TI - Degradation of chlorambucil in aqueous solution JO - J Pharm Sci VL - 69 UR - https://doi.org/10.1002/jps.2600690928 DO - 10.1002/jps.2600690928 ID - Ehrsson1980 ER - TY - JOUR AU - Gilad, Y. AU - Firer, M. AU - Gellerman, G. PY - 2016 DA - 2016// TI - Recent Innovations in peptide based targeted drug delivery to cancer cells JO - Biomedicines VL - 4 UR - https://doi.org/10.3390/biomedicines4020011 DO - 10.3390/biomedicines4020011 ID - Gilad2016 ER -